Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
MRI in multiple sclerosis: what's inside the toolbox?
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.
Disappearing MS T2 lesions may have persistent tissue injury by diffusion tensor and magnetisation transfer imaging
LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis.
Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.
Protective Effects of PGC-1α via the Mitochondrial Pathway in Rat Brains after Intracerebral Hemorrhage.
Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial.
Disability as an outcome in MS clinical trials.
MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability.
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Gray matter imaging in multiple sclerosis: what have we learned?
Mouse models for multiple sclerosis: historical facts and future implications.
Gray matter atrophy in multiple sclerosis: a longitudinal study.
Safety study of BIIB033 in subjects with multiple sclerosis
Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
Is progressive multiple sclerosis a gray matter disease?
Experimental autoimmune encephalomyelitis in the mouse.
MS Drugs in Development: Firategrast, Ocrelizumab, and Ofatumumab
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS.
Depletion of B cells by a humanized anti-CD20 antibody PRO70769 in Macaca fascicularis.
LINGO-1 negatively regulates myelination by oligodendrocytes.
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
An Electrophoretic Study of the Protein Components in Cerebrospinal Fluid and their Relationship to the Serum Proteins.
Autoimmunity's next top models.